Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01597752Phase 2Completed
A Phase 2 trial of blomia tropicalis allergen extract in Blomia tropicalis allergy, sponsored by LETI Pharma. Started Apr 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01597752.